Authors: VANNIEKERK CC VOOIJS P CASPARIEVANVELSEN IJ POELS LG

Citation: Cc. Vanniekerk et al., DIFFERENTIATION MARGINS OF OVARIAN TUMOR PATHOLOGY - FIRST INCIDENCESOF EPITHELIAL OVARIAN-TUMORS MONITORED BY MARKER ANTIBODIES, Cancer detection and prevention, 21(3), 1997, pp. 247-257

Authors: MIJNHEERE EP BOERMAN OC POELS LG SLOBBE RL VANEYS GJJM RAMAEKERS FCS

Citation: Ep. Mijnheere et al., PHARMACOKINETICS, BIODISTRIBUTION AND DOSIMETRY OF ANTI-NCAM MONOCLONAL-ANTIBODY RNL-1 AND ITS FRAGMENTS IN EXPERIMENTAL LUNG-CANCER, Journal of experimental & clinical cancer research, 15(1), 1996, pp. 11-18

Authors: NASSANDER UK STEERENBERG PA DEJONG WH VANOVERVELD WOWM BOEKHORST CMET POELS LG JAP PHK STORM G

Citation: Uk. Nassander et al., DESIGN OF IMMUNOLIPOSOMES DIRECTED AGAINST HUMAN OVARIAN-CARCINOMA, Biochimica et biophysica acta. Biomembranes, 1235(1), 1995, pp. 126-139

Authors: BAARS JH DERUIJTER JLM SMEDTS F VANNIEKERK CC POELS LG SELDENRIJK CA RAMAEKERS FCS

Citation: Jh. Baars et al., THE APPLICABILITY OF A KERATIN 7 MONOCLONAL-ANTIBODY IN ROUTINELY PAPANICOLAOU-STAINED CYTOLOGIC SPECIMENS FOR THE DIFFERENTIAL-DIAGNOSIS OF CARCINOMAS, American journal of clinical pathology, 101(3), 1994, pp. 257-261

Authors: CUIJPERS VMJI BOERMAN OC VANDEPOL MRJS VOOIJS GP POELS LG RAMAEKERS FCS

Citation: Vmji. Cuijpers et al., IMMUNOCYTOCHEMICAL DETECTION OF OVARIAN-CARCINOMA CELLS IN SEROUS EFFUSIONS, Acta cytologica, 37(3), 1993, pp. 272-279